# Reversal of Atrial Substrate to Prevent Atrial Fibrillation Pilot Study

> **NCT03186976** · NA · COMPLETED · sponsor: **Nova Scotia Health Authority** · enrollment: 12 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **BEHAVIORAL:** Aggressive Risk Factor Control
- **OTHER:** Standard of Care

## Key facts

- **NCT ID:** NCT03186976
- **Lead sponsor:** Nova Scotia Health Authority
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-01
- **Primary completion:** 2019-10-31
- **Final completion:** 2019-11-30
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2019-12-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03186976

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03186976, "Reversal of Atrial Substrate to Prevent Atrial Fibrillation Pilot Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03186976. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*